Reaction
Catheter Site Thrombosis reporting signals
As of the last recalculation, Catheter Site Thrombosis appears in 266 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 95.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 15 | 95.0 | 95.1 |
| Teduglutide | 14 | 85.8 | 85.8 |
| Polatuzumab Vedotin | 8 | 66.1 | 66.2 |
| Panitumumab | 10 | 51.9 | 51.9 |
| Bendamustine Hcl | 8 | 41.6 | 41.6 |
| Blinatumomab | 5 | 38.2 | 38.2 |